Sensible Biotechnologies key facts
- Developer of he world's first cell-based design, optimisation and manufacturing platform to make pure, non-immunogenic, and highly functional messenger RNA (mRNA) to unlock the next generation of…
- It has raised $13.8M; the latest was Seed Round ($3.0M) in Nov 2024.
- Notable investors include Y Combinator, Endless Frontier Labs, Tiny Supercomputer Investment Company, Possible Ventures, ZAKA VC — 25 tracked in total.
- Status: Privately Held (backing).
Who backs Sensible Biotechnologies
25+- ·The complete investor list: 25 names
- ·Watch Sensible Biotechnologies: the Monday email on marks, rounds and moves
Sensible Biotechnologies funding rounds
No funding rounds for Sensible Biotechnologies are on record yet — either the company hasn't raised institutional capital, or the raise hasn't surfaced in our sources.
Sensible Biotechnologies investors
25 investors are on record for Sensible Biotechnologies, including Y Combinator, Endless Frontier Labs, Tiny Supercomputer Investment Company and Possible Ventures. By type, the record holds 5 venture capital firms and 1 fund of funds.
About Sensible Biotechnologies
Developer of he world's first cell-based design, optimisation and manufacturing platform to make pure, non-immunogenic, and highly functional messenger RNA (mRNA) to unlock the next generation of messenger RNA (mRNA) medicines. The company's platform uses cell engineering, computational biology, and precision fermentation to optimize the production of vaccinia capping enzymes, enabling the healthcare industry to provide optimal medicines to their patients and improve accessibility to next-generation treatments.
- Sector
- Healthcare
- HQ
- Cambridge, MA, United States
- Founded
- 2021
- Employees
- 25
- Website
- sensible.bio/
- Ownership
- Privately Held (backing)
Is this your company? Sign in with your work email to keep it current, or tell us what's wrong.
Sensible Biotechnologies doesn't have a valuation on record yet — one is published once a priced round, a reported valuation, fund marks, or secondary prints surface in our sources. The rest of the record below builds toward it.